Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive day…
Biotechnology
US, Plymouth Meeting [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Harmony Biosciences Holdings, Inc. (HRMY) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 38,146.92 | 13,169.13 | 609.80 | 323.42 | -1,084.60 | 0.00 | 23.4514 | 42.97 | -0.7923 | -20.0249 | -0.07 | -0.07 | 6.3188 | - - | ||
| Maximum | - - | - - | - - | 1,535,067.00 | 609,984.00 | 35,800.00 | 99,050.00 | 5,421.00 | 0.02 | 1,336.3467 | 2,849.43 | 3.0051 | 85.3485 | 0.38 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Nuvalent, Inc. NUVL | 94.93 | 2.20 2.37% | 402 vs. 535 | 6,745.00 | 0.00 | -44.00 | -36.00 | -330.00 | -0.6900 | -27.7942 | 0.0000 | 0.0000 | 0.0000 | -0.0659 | -0.0628 | 20.6970 | 71.00 | ||
| Structure Therapeutics Inc. GPCR | 33.41 | 3.31 11.00% | 1,205 vs. 713 | 1,912.00 | 0.00 | -26.00 | -34.00 | -232.00 | -0.5600 | -18.2892 | 0.0000 | 0.0000 | 0.0000 | -0.0606 | -0.0569 | 18.5046 | 57.00 | ||
| Revolution Medicines, Inc. RVMD | 56.75 | -0.03 -0.05% | 1,139 vs. 1,174 | 9,546.00 | 0.00 | -116.00 | -163.00 | -1,253.00 | -0.7000 | -11.2467 | 0.0000 | 0.0000 | 0.0000 | -0.0672 | -0.0608 | 18.1763 | 168.00 | ||
| IDEAYA Biosciences, Inc. IDYA | 26.79 | 0.19 0.71% | 1,154 vs. 766 | 2,315.00 | 0.00 | -39.00 | -45.00 | -387.00 | -0.5300 | -20.1760 | 0.0000 | 0.0000 | 0.0000 | -0.0423 | -0.0412 | 27.9963 | 86.00 | ||
| Cerevel Therapeutics Holdings, Inc. CERE | 44.96 | 0.33 0.74% | 15,033 vs. 2,056 | 8,191.00 | 0.00 | -131.00 | -119.00 | -1,532.00 | -0.7300 | -14.5661 | 0.0000 | 0.0000 | 0.0000 | -0.2337 | -0.1170 | 10.1215 | 182.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.